APO Research
Talk to an analyst

APO RESEARCH · REPORT

Iloperidone Drugs

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global Iloperidone Drugs Market Outlook and Growth Opportunities 2026

2 January 2026190 pages

Choose your research edition.

Industry ResearchIloperidone Drugs Industry Research Report 2026117 pages · $2,950 USDIndustry Growth & TrendsGlobal Iloperidone Drugs Industry Growth and Trends Forecast to 203290 pages · $3,450 USDMarket StructureGlobal Iloperidone Drugs Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032189 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Iloperidone Drugs Market Outlook and Growth Opportunities 2026190 pages · $4,250 USDMarket Analysis & ForecastGlobal Iloperidone Drugs Market Analysis and Forecast 2026-2032192 pages · $4,950 USD

Market perspective

The global Iloperidone Drugs market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Iloperidone Drugs is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Iloperidone Drugs is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Iloperidone Drugs is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Iloperidone Drugs market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Iloperidone Drugs market include Alembic Pharmaceuticals, CSPC, Hansoh Pharma, Inventia, Taro Pharmaceutical and Vanda, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Iloperidone Drugs market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Iloperidone Drugs and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Iloperidone Drugs sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Iloperidone Drugs market size, projected growth trends, production technologies, key applications, and end-use industries.

Iloperidone Drugs Segment by Company

Alembic Pharmaceuticals

CSPC

Hansoh Pharma

Inventia

Taro Pharmaceutical

Vanda

Iloperidone Drugs Segment by Type

Brand Drugs

Generic Drugs

Iloperidone Drugs Segment by Application

Schizophrenia

Others

Iloperidone Drugs Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Study Objectives

1. To analyze and research the global Iloperidone Drugs status and future forecast, involving, sales, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions Iloperidone Drugs market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Iloperidone Drugs significant trends, drivers, influence factors in global and regions.

6. To analyze Iloperidone Drugs competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Iloperidone Drugs market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Iloperidone Drugs and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Iloperidone Drugs.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Iloperidone Drugs market, including product definition, global market growth prospects, sales value, sales volume, and average price forecasts (2021-2032).

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Iloperidone Drugs industry.

Chapter 3: Detailed analysis of Iloperidone Drugs manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales and value of Iloperidone Drugs in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 7: Sales and value of Iloperidone Drugs in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Iloperidone Drugs Industry Trends Table 2. Iloperidone Drugs Industry Drivers Table 3. Iloperidone Drugs Industry Opportunities and Challenges Table 4. Iloperidone Drugs Industry Restraints Table 5. Global Iloperidone Drugs Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Iloperidone Drugs Revenue Share by Company (2021-2026) Table 7. Global Iloperidone Drugs Sales Volume by Company (K Units) & (2021-2026) Table 8. Global Iloperidone Drugs Sales Volume Share by Company (2021-2026) Table 9. Global Iloperidone Drugs Average Price (US$/Unit) of Company (2021-2026) Table 10. Global Iloperidone Drugs Company Ranking, (2024-2026) & (USD Million) Table 11. Global Iloperidone Drugs Key Company Manufacturing Base & Headquarters Table 12. Global Iloperidone Drugs Company, Product Type & Application Table 13. Global Iloperidone Drugs Company Establishment Date Table 14. Global Company Market Concentration Ratio (CR5 and HHI) Table 15. Global Iloperidone Drugs by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 16. Mergers & Acquisitions, Expansion Table 17. Significant Companies of Brand Drugs Table 18. Significant Companies of Generic Drugs Table 19. Global Iloperidone Drugs Sales Volume by Type 2021 VS 2025 VS 2032 (K Units) Table 20. Global Iloperidone Drugs Sales Volume by Type (2021-2026) & (K Units) Table 21. Global Iloperidone Drugs Sales Volume by Type (2027-2032) & (K Units) Table 22. Global Iloperidone Drugs Sales Volume Share by Type (2021-2026) Table 23. Global Iloperidone Drugs Sales Volume Share by Type (2027-2032) Table 24. Global Iloperidone Drugs Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 25. Global Iloperidone Drugs Sales Value by Type (2021-2026) & (US$ Million) Table 26. Global Iloperidone Drugs Sales Value by Type (2027-2032) & (US$ Million) Table 27. Global Iloperidone Drugs Sales Value Share by Type (2021-2026) Table 28. Global Iloperidone Drugs Sales Value Share by Type (2027-2032) Table 29. Significant Companies of Schizophrenia Table 30. Significant Companies of Others Table 31. Global Iloperidone Drugs Sales Volume by Application 2021 VS 2025 VS 2032 (K Units) Table 32. Global Iloperidone Drugs Sales Volume by Application (2021-2026) & (K Units) Table 33. Global Iloperidone Drugs Sales Volume by Application (2027-2032) & (K Units) Table 34. Global Iloperidone Drugs Sales Volume Share by Application (2021-2026) Table 35. Global Iloperidone Drugs Sales Volume Share by Application (2027-2032) Table 36. Global Iloperidone Drugs Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 37. Global Iloperidone Drugs Sales Value by Application (2021-2026) & (US$ Million) Table 38. Global Iloperidone Drugs Sales Value by Application (2027-2032) & (US$ Million) Table 39. Global Iloperidone Drugs Sales Value Share by Application (2021-2026) Table 40. Global Iloperidone Drugs Sales Value Share by Application (2027-2032) Table 41. Global Iloperidone Drugs Sales by Region: 2021 VS 2025 VS 2032 (K Units) Table 42. Global Iloperidone Drugs Sales by Region (2021-2026) & (K Units) Table 43. Global Iloperidone Drugs Sales Market Share by Region (2021-2026) Table 44. Global Iloperidone Drugs Sales by Region (2027-2032) & (K Units) Table 45. Global Iloperidone Drugs Sales Market Share by Region (2027-2032) Table 46. Global Iloperidone Drugs Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 47. Global Iloperidone Drugs Sales Value by Region (2021-2026) & (US$ Million) Table 48. Global Iloperidone Drugs Sales Value Share by Region (2021-2026) Table 49. Global Iloperidone Drugs Sales Value by Region (2027-2032) & (US$ Million) Table 50. Global Iloperidone Drugs Sales Value Share by Region (2027-2032) Table 51. Global Iloperidone Drugs Market Average Price (US$/Unit) by Region (2021-2026) Table 52. Global Iloperidone Drugs Market Average Price (US$/Unit) by Region (2027-2032) Table 53. Global Iloperidone Drugs Sales by Country: 2021 VS 2025 VS 2032 (K Units) Table 54. Global Iloperidone Drugs Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 55. Global Iloperidone Drugs Sales by Country (2021-2026) & (K Units) Table 56. Global Iloperidone Drugs Sales Market Share by Country (2021-2026) Table 57. Global Iloperidone Drugs Sales by Country (2027-2032) & (K Units) Table 58. Global Iloperidone Drugs Sales Market Share by Country (2027-2032) Table 59. Global Iloperidone Drugs Sales Value by Country (2021-2026) & (US$ Million) Table 60. Global Iloperidone Drugs Sales Value Market Share by Country (2021-2026) Table 61. Global Iloperidone Drugs Sales Value by Country (2027-2032) & (US$ Million) Table 62. Global Iloperidone Drugs Sales Value Market Share by Country (2027-2032) Table 63. Alembic Pharmaceuticals Company Information Table 64. Alembic Pharmaceuticals Business Overview Table 65. Alembic Pharmaceuticals Iloperidone Drugs Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 66. Alembic Pharmaceuticals Iloperidone Drugs Product Portfolio Table 67. Alembic Pharmaceuticals Recent Development Table 68. CSPC Company Information Table 69. CSPC Business Overview Table 70. CSPC Iloperidone Drugs Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 71. CSPC Iloperidone Drugs Product Portfolio Table 72. CSPC Recent Development Table 73. Hansoh Pharma Company Information Table 74. Hansoh Pharma Business Overview Table 75. Hansoh Pharma Iloperidone Drugs Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 76. Hansoh Pharma Iloperidone Drugs Product Portfolio Table 77. Hansoh Pharma Recent Development Table 78. Inventia Company Information Table 79. Inventia Business Overview Table 80. Inventia Iloperidone Drugs Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 81. Inventia Iloperidone Drugs Product Portfolio Table 82. Inventia Recent Development Table 83. Taro Pharmaceutical Company Information Table 84. Taro Pharmaceutical Business Overview Table 85. Taro Pharmaceutical Iloperidone Drugs Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 86. Taro Pharmaceutical Iloperidone Drugs Product Portfolio Table 87. Taro Pharmaceutical Recent Development Table 88. Vanda Company Information Table 89. Vanda Business Overview Table 90. Vanda Iloperidone Drugs Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 91. Vanda Iloperidone Drugs Product Portfolio Table 92. Vanda Recent Development Table 93. Key Raw Materials Table 94. Raw Materials Key Suppliers Table 95. Iloperidone Drugs Distributors List Table 96. Iloperidone Drugs Customers List Table 97. Research Programs/Design for This Report Table 98. Authors List of This Report Table 99. Secondary Sources Table 100. Primary Sources List of Figures Figure 1. Iloperidone Drugs Product Image Figure 2. Global Iloperidone Drugs Sales Value (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Iloperidone Drugs Sales Value (2021-2032) & (US$ Million) Figure 4. Global Iloperidone Drugs Sales (2021-2032) & (K Units) Figure 5. Global Iloperidone Drugs Sales Average Price (US$/Unit) & (2021-2032) Figure 6. Global Iloperidone Drugs Company Revenue Ranking in 2025 (US$ Million) Figure 7. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 8. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 9. Brand Drugs Image Figure 10. Generic Drugs Image Figure 11. Global Iloperidone Drugs Sales Volume by Type (2021 VS 2025 VS 2032) & (K Units) Figure 12. Global Iloperidone Drugs Sales Volume Share 2021 VS 2025 VS 2032 Figure 13. Global Iloperidone Drugs Sales Volume Share by Type (2021-2032) Figure 14. Global Iloperidone Drugs Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 15. Global Iloperidone Drugs Sales Value Share 2021 VS 2025 VS 2032 Figure 16. Global Iloperidone Drugs Sales Value Share by Type (2021-2032) Figure 17. Schizophrenia Image Figure 18. Others Image Figure 19. Global Iloperidone Drugs Sales Volume by Application (2021 VS 2025 VS 2032) & (K Units) Figure 20. Global Iloperidone Drugs Sales Volume Share 2021 VS 2025 VS 2032 Figure 21. Global Iloperidone Drugs Sales Volume Share by Application (2021-2032) Figure 22. Global Iloperidone Drugs Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 23. Global Iloperidone Drugs Sales Value Share 2021 VS 2025 VS 2032 Figure 24. Global Iloperidone Drugs Sales Value Share by Application (2021-2032) Figure 25. Global Iloperidone Drugs Sales by Region: 2021 VS 2025 VS 2032 (K Units) Figure 26. Global Iloperidone Drugs Sales Market Share by Region: 2021 VS 2025 VS 2032 Figure 27. Global Iloperidone Drugs Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 28. Global Iloperidone Drugs Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 29. North America Iloperidone Drugs Sales Value (2021-2032) & (US$ Million) Figure 30. North America Iloperidone Drugs Sales Value Share by Country (%), 2025 VS 2032 Figure 31. Europe Iloperidone Drugs Sales Value (2021-2032) & (US$ Million) Figure 32. Europe Iloperidone Drugs Sales Value Share by Country (%), 2025 VS 2032 Figure 33. Asia-Pacific Iloperidone Drugs Sales Value (2021-2032) & (US$ Million) Figure 34. Asia-Pacific Iloperidone Drugs Sales Value Share by Country (%), 2025 VS 2032 Figure 35. South America Iloperidone Drugs Sales Value (2021-2032) & (US$ Million) Figure 36. South America Iloperidone Drugs Sales Value Share by Country (%), 2025 VS 2032 Figure 37. Middle East & Africa Iloperidone Drugs Sales Value (2021-2032) & (US$ Million) Figure 38. Middle East & Africa Iloperidone Drugs Sales Value Share by Country (%), 2025 VS 2032 Figure 39. USA Iloperidone Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 40. USA Iloperidone Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 41. USA Iloperidone Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 42. Canada Iloperidone Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 43. Canada Iloperidone Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 44. Canada Iloperidone Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 45. Mexico Iloperidone Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 46. Mexico Iloperidone Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 47. Mexico Iloperidone Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 48. Germany Iloperidone Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 49. Germany Iloperidone Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 50. Germany Iloperidone Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 51. France Iloperidone Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 52. France Iloperidone Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 53. France Iloperidone Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 54. U.K. Iloperidone Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 55. U.K. Iloperidone Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 56. U.K. Iloperidone Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 57. Italy Iloperidone Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 58. Italy Iloperidone Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 59. Italy Iloperidone Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 60. Spain Iloperidone Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 61. Spain Iloperidone Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 62. Spain Iloperidone Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 63. Russia Iloperidone Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 64. Russia Iloperidone Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 65. Russia Iloperidone Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 66. Netherlands Iloperidone Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 67. Netherlands Iloperidone Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 68. Netherlands Iloperidone Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 69. Nordic Countries Iloperidone Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 70. Nordic Countries Iloperidone Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 71. Nordic Countries Iloperidone Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 72. China Iloperidone Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 73. China Iloperidone Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 74. China Iloperidone Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 75. Japan Iloperidone Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 76. Japan Iloperidone Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 77. Japan Iloperidone Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 78. South Korea Iloperidone Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 79. South Korea Iloperidone Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 80. South Korea Iloperidone Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 81. India Iloperidone Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 82. India Iloperidone Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 83. India Iloperidone Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 84. Australia Iloperidone Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 85. Australia Iloperidone Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 86. Australia Iloperidone Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 87. Southeast Asia Iloperidone Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 88. Southeast Asia Iloperidone Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 89. Southeast Asia Iloperidone Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 90. Brazil Iloperidone Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 91. Brazil Iloperidone Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 92. Brazil Iloperidone Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 93. Argentina Iloperidone Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 94. Argentina Iloperidone Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 95. Argentina Iloperidone Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 96. Chile Iloperidone Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 97. Chile Iloperidone Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 98. Chile Iloperidone Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 99. Colombia Iloperidone Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 100. Colombia Iloperidone Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 101. Colombia Iloperidone Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 102. Peru Iloperidone Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 103. Peru Iloperidone Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 104. Peru Iloperidone Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 105. Saudi Arabia Iloperidone Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 106. Saudi Arabia Iloperidone Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 107. Saudi Arabia Iloperidone Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 108. Israel Iloperidone Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 109. Israel Arabia Iloperidone Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 110. Israel Arabia Iloperidone Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 111. UAE Iloperidone Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 112. UAE Iloperidone Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 113. UAE Iloperidone Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 114. Turkey Iloperidone Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 115. Turkey Iloperidone Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 116. Turkey Iloperidone Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 117. Iran Iloperidone Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 118. Iran Iloperidone Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 119. Iran Iloperidone Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 120. Egypt Iloperidone Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 121. Egypt Iloperidone Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 122. Egypt Iloperidone Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 123. Iloperidone Drugs Value Chain Figure 124. Manufacturing Cost Structure Figure 125. Iloperidone Drugs Sales Mode & Process Figure 126. Direct Comparison with Distribution Share Figure 127. Distributors Profiles Figure 128. Years Considered Figure 129. Research Process Figure 130. Key Executives Interviewed

Scope & coverage.

Types
  • Brand Drugs
  • Generic Drugs
Applications
  • Schizophrenia
  • Others
Companies covered
  • Alembic Pharmaceuticals
  • CSPC
  • Hansoh Pharma
  • Inventia
  • Taro Pharmaceutical
  • Vanda

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Iloperidone Drugs Sales Value (2021-2032)
  4. 1.2.2 Global Iloperidone Drugs Sales Volume (2021-2032)
  5. 1.2.3 Global Iloperidone Drugs Sales Average Price (2021-2032)
  6. 1.3 Assumptions and Limitations
  7. 1.4 Study Goals and Objectives
2 Iloperidone Drugs Market Dynamics
  1. 2.1 Iloperidone Drugs Industry Trends
  2. 2.2 Iloperidone Drugs Industry Drivers
  3. 2.3 Iloperidone Drugs Industry Opportunities and Challenges
  4. 2.4 Iloperidone Drugs Industry Restraints
3 Iloperidone Drugs Market by Company
  1. 3.1 Global Iloperidone Drugs Company Revenue Ranking in 2025
  2. 3.2 Global Iloperidone Drugs Revenue by Company (2021-2026)
  3. 3.3 Global Iloperidone Drugs Sales Volume by Company (2021-2026)
  4. 3.4 Global Iloperidone Drugs Average Price by Company (2021-2026)
  5. 3.5 Global Iloperidone Drugs Company Ranking (2024-2026)
  6. 3.6 Global Iloperidone Drugs Company Manufacturing Base and Headquarters
  7. 3.7 Global Iloperidone Drugs Company Product Type and Application
  8. 3.8 Global Iloperidone Drugs Company Establishment Date
  9. 3.9 Market Competitive Analysis
  10. 3.9.1 Global Iloperidone Drugs Market Concentration Ratio (CR5 and HHI)
  11. 3.9.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  12. 3.9.3 2025 Iloperidone Drugs Tier 1, Tier 2, and Tier 3 Companies
  13. 3.10 Mergers and Acquisitions Expansion
4 Iloperidone Drugs Market by Type
  1. 4.1 Iloperidone Drugs Type Introduction
  2. 4.1.1 Brand Drugs
  3. 4.1.2 Generic Drugs
  4. 4.2 Global Iloperidone Drugs Sales Volume by Type
  5. 4.2.1 Global Iloperidone Drugs Sales Volume by Type (2021 VS 2025 VS 2032)
  6. 4.2.2 Global Iloperidone Drugs Sales Volume by Type (2021-2032)
  7. 4.2.3 Global Iloperidone Drugs Sales Volume Share by Type (2021-2032)
  8. 4.3 Global Iloperidone Drugs Sales Value by Type
  9. 4.3.1 Global Iloperidone Drugs Sales Value by Type (2021 VS 2025 VS 2032)
  10. 4.3.2 Global Iloperidone Drugs Sales Value by Type (2021-2032)
  11. 4.3.3 Global Iloperidone Drugs Sales Value Share by Type (2021-2032)
5 Iloperidone Drugs Market by Application
  1. 5.1 Iloperidone Drugs Application Introduction
  2. 5.1.1 Schizophrenia
  3. 5.1.2 Others
  4. 5.2 Global Iloperidone Drugs Sales Volume by Application
  5. 5.2.1 Global Iloperidone Drugs Sales Volume by Application (2021 VS 2025 VS 2032)
  6. 5.2.2 Global Iloperidone Drugs Sales Volume by Application (2021-2032)
  7. 5.2.3 Global Iloperidone Drugs Sales Volume Share by Application (2021-2032)
  8. 5.3 Global Iloperidone Drugs Sales Value by Application
  9. 5.3.1 Global Iloperidone Drugs Sales Value by Application (2021 VS 2025 VS 2032)
  10. 5.3.2 Global Iloperidone Drugs Sales Value by Application (2021-2032)
  11. 5.3.3 Global Iloperidone Drugs Sales Value Share by Application (2021-2032)
6 Iloperidone Drugs Regional Sales and Value Analysis
  1. 6.1 Global Iloperidone Drugs Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Iloperidone Drugs Sales by Region (2021-2032)
  3. 6.2.1 Global Iloperidone Drugs Sales by Region: 2021-2026
  4. 6.2.2 Global Iloperidone Drugs Sales by Region (2027-2032)
  5. 6.3 Global Iloperidone Drugs Sales Value by Region: 2021 VS 2025 VS 2032
  6. 6.4 Global Iloperidone Drugs Sales Value by Region (2021-2032)
  7. 6.4.1 Global Iloperidone Drugs Sales Value by Region: 2021-2026
  8. 6.4.2 Global Iloperidone Drugs Sales Value by Region (2027-2032)
  9. 6.5 Global Iloperidone Drugs Market Price Analysis by Region (2021-2026)
  10. 6.6 North America
  11. 6.6.1 North America Iloperidone Drugs Sales Value (2021-2032)
  12. 6.6.2 North America Iloperidone Drugs Sales Value Share by Country, 2025 VS 2032
  13. 6.7 Europe
  14. 6.7.1 Europe Iloperidone Drugs Sales Value (2021-2032)
  15. 6.7.2 Europe Iloperidone Drugs Sales Value Share by Country, 2025 VS 2032
  16. 6.8 Asia-Pacific
  17. 6.8.1 Asia-Pacific Iloperidone Drugs Sales Value (2021-2032)
  18. 6.8.2 Asia-Pacific Iloperidone Drugs Sales Value Share by Country, 2025 VS 2032
  19. 6.9 South America
  20. 6.9.1 South America Iloperidone Drugs Sales Value (2021-2032)
  21. 6.9.2 South America Iloperidone Drugs Sales Value Share by Country, 2025 VS 2032
  22. 6.10 Middle East & Africa
  23. 6.10.1 Middle East & Africa Iloperidone Drugs Sales Value (2021-2032)
  24. 6.10.2 Middle East & Africa Iloperidone Drugs Sales Value Share by Country, 2025 VS 2032
7 Iloperidone Drugs Country-level Sales and Value Analysis
  1. 7.1 Global Iloperidone Drugs Sales by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Iloperidone Drugs Sales Value by Country: 2021 VS 2025 VS 2032
  3. 7.3 Global Iloperidone Drugs Sales by Country (2021-2032)
  4. 7.3.1 Global Iloperidone Drugs Sales by Country (2021-2026)
  5. 7.3.2 Global Iloperidone Drugs Sales by Country (2027-2032)
  6. 7.4 Global Iloperidone Drugs Sales Value by Country (2021-2032)
  7. 7.4.1 Global Iloperidone Drugs Sales Value by Country (2021-2026)
  8. 7.4.2 Global Iloperidone Drugs Sales Value by Country (2027-2032)
  9. 7.5 USA
  10. 7.5.1 USA Iloperidone Drugs Sales Value Growth Rate (2021-2032)
  11. 7.5.2 USA Iloperidone Drugs Sales Value Share by Type, 2025 VS 2032
  12. 7.5.3 USA Iloperidone Drugs Sales Value Share by Application, 2025 VS 2032
  13. 7.6 Canada
  14. 7.6.1 Canada Iloperidone Drugs Sales Value Growth Rate (2021-2032)
  15. 7.6.2 Canada Iloperidone Drugs Sales Value Share by Type, 2025 VS 2032
  16. 7.6.3 Canada Iloperidone Drugs Sales Value Share by Application, 2025 VS 2032
  17. 7.7 Mexico
  18. 7.6.1 Mexico Iloperidone Drugs Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Mexico Iloperidone Drugs Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Mexico Iloperidone Drugs Sales Value Share by Application, 2025 VS 2032
  21. 7.8 Germany
  22. 7.8.1 Germany Iloperidone Drugs Sales Value Growth Rate (2021-2032)
  23. 7.8.2 Germany Iloperidone Drugs Sales Value Share by Type, 2025 VS 2032
  24. 7.8.3 Germany Iloperidone Drugs Sales Value Share by Application, 2025 VS 2032
  25. 7.9 France
  26. 7.9.1 France Iloperidone Drugs Sales Value Growth Rate (2021-2032)
  27. 7.9.2 France Iloperidone Drugs Sales Value Share by Type, 2025 VS 2032
  28. 7.9.3 France Iloperidone Drugs Sales Value Share by Application, 2025 VS 2032
  29. 7.10 U.K.
  30. 7.10.1 U.K. Iloperidone Drugs Sales Value Growth Rate (2021-2032)
  31. 7.10.2 U.K. Iloperidone Drugs Sales Value Share by Type, 2025 VS 2032
  32. 7.10.3 U.K. Iloperidone Drugs Sales Value Share by Application, 2025 VS 2032
  33. 7.11 Italy
  34. 7.11.1 Italy Iloperidone Drugs Sales Value Growth Rate (2021-2032)
  35. 7.11.2 Italy Iloperidone Drugs Sales Value Share by Type, 2025 VS 2032
  36. 7.11.3 Italy Iloperidone Drugs Sales Value Share by Application, 2025 VS 2032
  37. 7.12 Spain
  38. 7.12.1 Spain Iloperidone Drugs Sales Value Growth Rate (2021-2032)
  39. 7.12.2 Spain Iloperidone Drugs Sales Value Share by Type, 2025 VS 2032
  40. 7.12.3 Spain Iloperidone Drugs Sales Value Share by Application, 2025 VS 2032
  41. 7.13 Russia
  42. 7.13.1 Russia Iloperidone Drugs Sales Value Growth Rate (2021-2032)
  43. 7.13.2 Russia Iloperidone Drugs Sales Value Share by Type, 2025 VS 2032
  44. 7.13.3 Russia Iloperidone Drugs Sales Value Share by Application, 2025 VS 2032
  45. 7.14 Netherlands
  46. 7.14.1 Netherlands Iloperidone Drugs Sales Value Growth Rate (2021-2032)
  47. 7.14.2 Netherlands Iloperidone Drugs Sales Value Share by Type, 2025 VS 2032
  48. 7.14.3 Netherlands Iloperidone Drugs Sales Value Share by Application, 2025 VS 2032
  49. 7.15 Nordic Countries
  50. 7.15.1 Nordic Countries Iloperidone Drugs Sales Value Growth Rate (2021-2032)
  51. 7.15.2 Nordic Countries Iloperidone Drugs Sales Value Share by Type, 2025 VS 2032
  52. 7.15.3 Nordic Countries Iloperidone Drugs Sales Value Share by Application, 2025 VS 2032
  53. 7.16 China
  54. 7.16.1 China Iloperidone Drugs Sales Value Growth Rate (2021-2032)
  55. 7.16.2 China Iloperidone Drugs Sales Value Share by Type, 2025 VS 2032
  56. 7.16.3 China Iloperidone Drugs Sales Value Share by Application, 2025 VS 2032
  57. 7.17 Japan
  58. 7.17.1 Japan Iloperidone Drugs Sales Value Growth Rate (2021-2032)
  59. 7.17.2 Japan Iloperidone Drugs Sales Value Share by Type, 2025 VS 2032
  60. 7.17.3 Japan Iloperidone Drugs Sales Value Share by Application, 2025 VS 2032
  61. 7.18 South Korea
  62. 7.18.1 South Korea Iloperidone Drugs Sales Value Growth Rate (2021-2032)
  63. 7.18.2 South Korea Iloperidone Drugs Sales Value Share by Type, 2025 VS 2032
  64. 7.18.3 South Korea Iloperidone Drugs Sales Value Share by Application, 2025 VS 2032
  65. 7.19 India
  66. 7.19.1 India Iloperidone Drugs Sales Value Growth Rate (2021-2032)
  67. 7.19.2 India Iloperidone Drugs Sales Value Share by Type, 2025 VS 2032
  68. 7.19.3 India Iloperidone Drugs Sales Value Share by Application, 2025 VS 2032
  69. 7.20 Australia
  70. 7.20.1 Australia Iloperidone Drugs Sales Value Growth Rate (2021-2032)
  71. 7.20.2 Australia Iloperidone Drugs Sales Value Share by Type, 2025 VS 2032
  72. 7.20.3 Australia Iloperidone Drugs Sales Value Share by Application, 2025 VS 2032
  73. 7.21 Southeast Asia
  74. 7.21.1 Southeast Asia Iloperidone Drugs Sales Value Growth Rate (2021-2032)
  75. 7.21.2 Southeast Asia Iloperidone Drugs Sales Value Share by Type, 2025 VS 2032
  76. 7.21.3 Southeast Asia Iloperidone Drugs Sales Value Share by Application, 2025 VS 2032
  77. 7.22 Brazil
  78. 7.22.1 Brazil Iloperidone Drugs Sales Value Growth Rate (2021-2032)
  79. 7.22.2 Brazil Iloperidone Drugs Sales Value Share by Type, 2025 VS 2032
  80. 7.22.3 Brazil Iloperidone Drugs Sales Value Share by Application, 2025 VS 2032
  81. 7.23 Argentina
  82. 7.23.1 Argentina Iloperidone Drugs Sales Value Growth Rate (2021-2032)
  83. 7.23.2 Argentina Iloperidone Drugs Sales Value Share by Type, 2025 VS 2032
  84. 7.23.3 Argentina Iloperidone Drugs Sales Value Share by Application, 2025 VS 2032
  85. 7.24 Chile
  86. 7.24.1 Chile Iloperidone Drugs Sales Value Growth Rate (2021-2032)
  87. 7.24.2 Chile Iloperidone Drugs Sales Value Share by Type, 2025 VS 2032
  88. 7.24.3 Chile Iloperidone Drugs Sales Value Share by Application, 2025 VS 2032
  89. 7.25 Colombia
  90. 7.25.1 Colombia Iloperidone Drugs Sales Value Growth Rate (2021-2032)
  91. 7.25.2 Colombia Iloperidone Drugs Sales Value Share by Type, 2025 VS 2032
  92. 7.25.3 Colombia Iloperidone Drugs Sales Value Share by Application, 2025 VS 2032
  93. 7.26 Peru
  94. 7.26.1 Peru Iloperidone Drugs Sales Value Growth Rate (2021-2032)
  95. 7.26.2 Peru Iloperidone Drugs Sales Value Share by Type, 2025 VS 2032
  96. 7.26.3 Peru Iloperidone Drugs Sales Value Share by Application, 2025 VS 2032
  97. 7.27 Saudi Arabia
  98. 7.27.1 Saudi Arabia Iloperidone Drugs Sales Value Growth Rate (2021-2032)
  99. 7.27.2 Saudi Arabia Iloperidone Drugs Sales Value Share by Type, 2025 VS 2032
  100. 7.27.3 Saudi Arabia Iloperidone Drugs Sales Value Share by Application, 2025 VS 2032
  101. 7.28 Israel
  102. 7.28.1 Israel Iloperidone Drugs Sales Value Growth Rate (2021-2032)
  103. 7.28.2 Israel Iloperidone Drugs Sales Value Share by Type, 2025 VS 2032
  104. 7.28.3 Israel Iloperidone Drugs Sales Value Share by Application, 2025 VS 2032
  105. 7.29 UAE
  106. 7.29.1 UAE Iloperidone Drugs Sales Value Growth Rate (2021-2032)
  107. 7.29.2 UAE Iloperidone Drugs Sales Value Share by Type, 2025 VS 2032
  108. 7.29.3 UAE Iloperidone Drugs Sales Value Share by Application, 2025 VS 2032
  109. 7.30 Turkey
  110. 7.30.1 Turkey Iloperidone Drugs Sales Value Growth Rate (2021-2032)
  111. 7.30.2 Turkey Iloperidone Drugs Sales Value Share by Type, 2025 VS 2032
  112. 7.30.3 Turkey Iloperidone Drugs Sales Value Share by Application, 2025 VS 2032
  113. 7.31 Iran
  114. 7.31.1 Iran Iloperidone Drugs Sales Value Growth Rate (2021-2032)
  115. 7.31.2 Iran Iloperidone Drugs Sales Value Share by Type, 2025 VS 2032
  116. 7.31.3 Iran Iloperidone Drugs Sales Value Share by Application, 2025 VS 2032
  117. 7.32 Egypt
  118. 7.32.1 Egypt Iloperidone Drugs Sales Value Growth Rate (2021-2032)
  119. 7.32.2 Egypt Iloperidone Drugs Sales Value Share by Type, 2025 VS 2032
  120. 7.32.3 Egypt Iloperidone Drugs Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Alembic Pharmaceuticals
  2. 8.1.1 Alembic Pharmaceuticals Company Information
  3. 8.1.2 Alembic Pharmaceuticals Business Overview
  4. 8.1.3 Alembic Pharmaceuticals Iloperidone Drugs Sales, Value and Gross Margin (2021-2026)
  5. 8.1.4 Alembic Pharmaceuticals Iloperidone Drugs Product Portfolio
  6. 8.1.5 Alembic Pharmaceuticals Recent Developments
  7. 8.2 CSPC
  8. 8.2.1 CSPC Company Information
  9. 8.2.2 CSPC Business Overview
  10. 8.2.3 CSPC Iloperidone Drugs Sales, Value and Gross Margin (2021-2026)
  11. 8.2.4 CSPC Iloperidone Drugs Product Portfolio
  12. 8.2.5 CSPC Recent Developments
  13. 8.3 Hansoh Pharma
  14. 8.3.1 Hansoh Pharma Company Information
  15. 8.3.2 Hansoh Pharma Business Overview
  16. 8.3.3 Hansoh Pharma Iloperidone Drugs Sales, Value and Gross Margin (2021-2026)
  17. 8.3.4 Hansoh Pharma Iloperidone Drugs Product Portfolio
  18. 8.3.5 Hansoh Pharma Recent Developments
  19. 8.4 Inventia
  20. 8.4.1 Inventia Company Information
  21. 8.4.2 Inventia Business Overview
  22. 8.4.3 Inventia Iloperidone Drugs Sales, Value and Gross Margin (2021-2026)
  23. 8.4.4 Inventia Iloperidone Drugs Product Portfolio
  24. 8.4.5 Inventia Recent Developments
  25. 8.5 Taro Pharmaceutical
  26. 8.5.1 Taro Pharmaceutical Company Information
  27. 8.5.2 Taro Pharmaceutical Business Overview
  28. 8.5.3 Taro Pharmaceutical Iloperidone Drugs Sales, Value and Gross Margin (2021-2026)
  29. 8.5.4 Taro Pharmaceutical Iloperidone Drugs Product Portfolio
  30. 8.5.5 Taro Pharmaceutical Recent Developments
  31. 8.6 Vanda
  32. 8.6.1 Vanda Company Information
  33. 8.6.2 Vanda Business Overview
  34. 8.6.3 Vanda Iloperidone Drugs Sales, Value and Gross Margin (2021-2026)
  35. 8.6.4 Vanda Iloperidone Drugs Product Portfolio
  36. 8.6.5 Vanda Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Iloperidone Drugs Value Chain Analysis
  2. 9.1.1 Iloperidone Drugs Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Iloperidone Drugs Sales Mode & Process
  6. 9.2 Iloperidone Drugs Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Iloperidone Drugs Distributors
  9. 9.2.3 Iloperidone Drugs Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst